Key Event
Mr. Shekhar Prasad Singh (DIN: 00969209) and Mr. Satyanaryana Murthy Chavali (DIN: 00142138) have ceased to be Non-Executive Independent Directors of the Company. The cessation is effective from the close of business hours on May 25, 2026, and is due to the completion of their respective tenures.
Company Statement
The Company placed on record its deep appreciation for the valuable services rendered by both directors and their significant contributions during their tenure as Independent Directors.
Detailed Director Disclosures (As per SEBI Master Circular)
The disclosure includes an annexure with details as required by SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
For Mr. Shekhar Prasad Singh (DIN: 00969209):
- Reason for Change: Cessation due to tenure completion.
- Date of Cessation: May 25, 2026 (Closing of business hours).
- Directorship in Listed Companies: Nil.
- Committee Position(s) in Listed Companies: Nil.
For Mr. Satyanaryana Murthy Chavali (DIN: 00142138):
- Reason for Change: Cessation due to tenure completion.
- Date of Cessation: May 25, 2026 (Closing of business hours).
- Directorship in Listed Companies: Gland Pharma Limited.
- Committee Position(s) in Listed Companies (at Gland Pharma Limited):
- Chairman of the Audit Committee
- Chairman of the Nomination & Remuneration Committee
- Chairman of the Stakeholders Relationship Committee & Share Transfer Committee
- Chairman of the ESOP Compensation Committee
Filing Details
The letter was dated May 25, 2026, and digitally signed by Ankit Shah, Chief Financial Officer of Vijaya Diagnostic Centre Limited, on the same date at 16:22:33 +05'30'.